Close
Digital Health & Ai Innovation summit 2026
APE 2026

Amedisys Inc to Acquire De Queen Home Health Agency

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA May Scrutinize Medical Device Cybersecurity...

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare...

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

Amedisys, Inc. announced the acquisition of De Queen Home Health Agency.  The acquisition is expected to expand the company’s coverage to all, or part, of eight new counties in Arkansas.  The company currently serves 32 counties in the state, including the eight from the acquisition.  De Queen’s annualized revenue is $2.9 million, although it is not expected to ad materially to the company’s earnings in 2010. 

Amedisys, Inc. (Amedisys) is a provider of home health services to the chronic, co-morbid, aging American population. The services that the Company provides include both home health and hospice services with approximately 87% of its revenue derived from Medicare. As of December 31, 2008, Amedisys owned and operated 480 Medicare-certified home health agencies, 48 Medicare-certified hospice agencies and managed the operations of four Medicare-certified home health and two Medicare-certified hospice agencies in 37 states within the United States, the District of Columbia and Puerto Rico. Its home health patient is Medicare eligible, approximately years old and takes approximately 12 different medications on a daily basis and has multiple co-morbidities. For the Company’s home health patients, it receives a 60-day, episodic-based payment from Medicare.

Latest stories

Related stories

FDA May Scrutinize Medical Device Cybersecurity More in 2026

The scrutiny by the US Food and Drug Administration...

Recon DL Tool from GE HealthCare Receives a PMA

Pristina Recon DL tool from GE HealthCare which uses...

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »